Reduction of the systemic inflammatory response in patients with CAP treated with corticosteroids improves clinical outcome and reduces mortality and ICU admittance

H. Remmelts, S. Meijvis, G. Rijkers, H. van Velzen-Blad, P. Voorn, J. Grutters, W. J. Bos, D. Biesma (Nieuwegein, Utrecht, Netherlands)

Source: Annual Congress 2011 - Pulmonary infections and sepsis
Session: Pulmonary infections and sepsis
Session type: Oral Presentation
Number: 3203
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
H. Remmelts, S. Meijvis, G. Rijkers, H. van Velzen-Blad, P. Voorn, J. Grutters, W. J. Bos, D. Biesma (Nieuwegein, Utrecht, Netherlands). Reduction of the systemic inflammatory response in patients with CAP treated with corticosteroids improves clinical outcome and reduces mortality and ICU admittance. Eur Respir J 2011; 38: Suppl. 55, 3203

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Reslizumab reduces severe exacerbations associated with emergency department visit or hospitalization and improves measures of lung function in patients on maintenance oral corticosteroids (OCS) at baseline
Source: International Congress 2017 – Asthma: mechanisms and treatment
Year: 2017


Is the use of CPAP before hospital admission effective to improve outcome in acute respiratory failure?
Source: Eur Respir J 2006; 28: Suppl. 50, 345s
Year: 2006

Impact of inhaled corticosteroid use on outcome in COPD patients hospitalised with pneumonia
Source: Annual Congress 2010 - Aetiology and outcomes of infective exacerbations of COPD
Year: 2010


Clinical pathway for acute COPD exacerbations reduces hospital stay and readmission rate
Source: Annual Congress 2008 - Impact of nursing interventions on the quality of care for COPD patients
Year: 2008


Clinical pathway for acute COPD exacerbations reduces hospital stay and readmission rate
Source: Eur Respir J 2006; 28: Suppl. 50, 131s
Year: 2006

A comparison of intravenous versus oral administration of corticosteroids in the treatment of patients admitted to the hospital with an exacerbation of COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 64s
Year: 2004

Dose dependent increased mortality risk in COPD patients treated with oral glucocorticoids
Source: Eur Respir J 2001; 17: 337-342
Year: 2001



Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: A randomized clinical trial
Source: International Congress 2015 – Acute critical care: news from the ICU
Year: 2015



Associations between clinical, laboratory and therapeutical parameters on admission and adverse outcomes in patients hospitalized for COPD exacerbations
Source: Annual Congress 2010 - Pharmacological modulation of biomarkers and management
Year: 2010


CAB score predicts short-term mortality at hospital admission for acute exacerbations of COPD
Source: International Congress 2017 – COPD management: new findings from large studies
Year: 2017



Acute effect of erdosteine on preventing recurrence of exacerbation in COPD patients after hospital discharge
Source: Annual Congress 2012 - Trials in COPD: novel treatments and insights
Year: 2012


Integrated care pathways significantly reduce drug dosing and administration errors in patients with acute asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 481s
Year: 2006

Faster clinical improvement and earlier discharge from hospital in CAP patients under sequential moxifloxacin treatment compared to standard therapy
Source: Eur Respir J 2004; 24: Suppl. 48, 188s
Year: 2004

Early pulmonary rehabilitation increases 6MWD and reduces CRP in hospitalized patients with severe AECOPD
Source: Virtual Congress 2020 – Comprehensive care and pulmonary rehabilitation for chronic respiratory diseases
Year: 2020


An unbalanced inflammatory response on admission impacts clinical stability in hospitalized patients with community-acquired pneumonia (CAP)
Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia
Year: 2011


Factors determining duration of hospital stay in patients hospitalized for acute COPD exacerbation
Source: Annual Congress 2011 - Monitoring exacerbations of airway diseases
Year: 2011

Study of clinical presentation and predictors of adverse outcome in patients admitted for acute exacerbation of COPD.
Source: International Congress 2019 – Airway disease-associated exacerbations
Year: 2019

Characteristics and outcome of patients admitted to intensive care with acute exacerbation of COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 393s
Year: 2006

The influence of inadequate starting empirical antimicrobial therapy of septic pneumonia on outcomes at patients with angiogenic sepsis
Source: Eur Respir J 2004; 24: Suppl. 48, 549s
Year: 2004

Community acquired pneumonia in the emergency department: Comparison of clinical indication to in-hospital treatment and severity scales predicting mortality
Source: Annual Congress 2012 - Respiratory infections: prognosis and outcome
Year: 2012